Vectus Biosystems Limited Banner Image

Vectus Biosystems Limited

  • Ticker VBS
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Vectus Biosystems Limited Logo Image
  • Based in Rosebery, Australia
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseasesMore, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that improves speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was founded in 2005 and is based in Rosebery, Australia.
4.8 / 5.0 (68)

Vectus Biosystems Limited reports have an aggregate usefulness score of 4.8 based on 68 reviews.

Vectus Biosystems Limited

Most Recent Annual Report

Vectus Biosystems Limited
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Vectus Biosystems Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!